Grafted Neurons That Won't Connect

Stroke, traumatic brain injury (TBI), and neurodegenerative diseases destroy neocortical tissue — the brain region responsible for cognition, language, motor planning, and personality. Unlike skin, liver, or blood, the adult mammalian neocortex does not regenerate. Lost neurons are not replaced; lost circuits are not rebuilt. The brain's response to injury is scar formation (glial scarring) that walls off damage but prevents new neurons from integrating. Stem cell transplantation into the brain has been attempted, but grafted cells either die, fail to differentiate into the correct neuronal subtypes, or fail to form functional synaptic connections with the host circuit. No therapy exists that can restore lost cognitive function after significant cortical tissue damage.

Stroke is the leading cause of adult disability worldwide, affecting 15 million people per year (5 million deaths, 5 million permanent disability). TBI affects 69 million people per year globally. Alzheimer's disease destroys cortical tissue in 55 million people worldwide. Current treatments — physical rehabilitation for stroke/TBI, cholinesterase inhibitors for Alzheimer's — manage symptoms but cannot restore lost tissue or function. The economic burden of stroke alone exceeds $56 billion annually in the U.S. If cortical tissue could be functionally restored, it would represent the first regenerative therapy for the central nervous system.

Neural stem cell transplantation has been tested in animal models and early clinical trials for stroke and TBI. Grafted cells can survive and differentiate into neurons, but they typically form disorganized clusters rather than the precisely layered six-layer cortical architecture required for function. Even when grafted neurons survive, they rarely form long-range connections with distant brain regions — the fiber tract connections that carry information between cortical areas. Organoid transplantation (grafting lab-grown brain organoids into damaged cortex) has shown more promising integration in rodent models, with grafted human neurons forming synaptic connections with host tissue, but organoids lack the vascular support, layered organization, and regional specification needed for functional contribution. iPSC-derived cortical neurons can be produced in large quantities but delivering them to the correct location, in the correct layer, with the correct connectivity pattern remains unsolved.

A method to convert non-neuronal cells already present in the damaged brain (astrocytes, fibroblasts in the scar tissue) into functional cortical neurons in situ — bypassing the need for transplantation — would be a major advance. Alternatively, engineered tissue grafts with pre-organized cortical layer structure, integrated vasculature, and guidance cues that direct axon outgrowth to appropriate targets could provide a transplantable solution. Both approaches require: (1) reliable in vivo or in vitro generation of layer-specific cortical neuron subtypes; (2) methods to promote axon extension from grafted neurons to distant targets through the adult brain's inhibitory environment; (3) assays to verify that grafted tissue is functionally integrated (not just anatomically present) and contributing to cognitive recovery.

A student team could develop protocols for differentiating iPSCs into specific cortical neuron subtypes (e.g., layer 5 pyramidal neurons) and characterize their electrophysiological properties in vitro, comparing them to native neurons. A bioengineering team could design a scaffold or microfluidic device that organizes neurons into layered structures mimicking cortical architecture and measures whether layer-specific connectivity patterns emerge. Relevant disciplines: neuroscience, stem cell biology, biomedical engineering, tissue engineering.